▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Brian Feroldi

TMFTypeoh

Brian Feroldi has been covering the healthcare and technology industries for The Motley Fool since 2015. Brian's investing strategy is to buy high-quality companies and then let compounding work its magic. See all of his articles here.

Recent Articles by Brian Feroldi

Business man facing a road that splits

Oct 17, 2017 by Brian Feroldi, Travis Hoium, and John Rosevear

3 Top Index Funds to Keep You in the Investing Game

Investing is a potent way to grow wealth, but picking individual stocks isn't for everyone. If you're seeking other options, consider the Schwab U.S. Small-Cap ETF, SPDR S&P 500 ETF, and Vanguard FTSE All-World ex-US ETF.

SenhanceSystemShot_TOTAL_022317

Oct 16, 2017 by Brian Feroldi

Why TransEnterix Is Skyrocketing Today

Shares soar after the company notches an important regulatory win.

Pills spilled on top of hundred dollar bills

Oct 12, 2017 by Brian Feroldi

Better Buy: CVS Health Corporation vs. Walgreens Boots Alliance

Let's put the two retail pharma giants to the test to determine which is the better bet for new money today.

Rolled up dollar bills stacked next to each other indicating growth

Oct 9, 2017 by Brian Feroldi and Demitri Kalogeropoulos

2 Stocks Your Children Will Brag About Someday

Here's why these two businesses are wonderful buy-and-hold candidates.

Older gentleman with a piggy bank in hand

Oct 7, 2017 by Brian Feroldi, Rich Duprey, and Demitri Kalogeropoulos

3 Stable Stocks for Conservative Investors

Looking for a few rock-solid businesses to buy? Here are three gems that you should consider.

Hands counting a big pile of cash

Oct 6, 2017 by Brian Feroldi, Reuben Gregg Brewer, and Keith Noonan

3 Stocks That Could Be Life-Changers

Looking for a few stocks that offer big-time profit potential? Take a look at these three businesses.

Business people giving the thumbs up

Oct 6, 2017 by Brian Feroldi, Reuben Gregg Brewer, and Keith Noonan

3 Top Stocks Wall Street Insiders Love

Looking for a few timely stock picks from the pros? Consider giving these three companies a closer look.

Picture of Cologuard testing kit

Oct 5, 2017 by Brian Feroldi

Why EXACT Sciences Corporation Jumped 13.2% in September

Bullish commentary from an analyst allowed Exact Sciences' huge rally to continue.

Arrows pointing down on chalkboard with business man in front of it

Oct 5, 2017 by Brian Feroldi

Why Glaukos Corp. Stock Sank 12.8% in September

Management poured cold water on its financial projections for 2017, causes shares to take a step back.

Oct 5, 2017 by Brian Feroldi

Here's Why Alnylam Pharmaceuticals Rallied 32.7% in September

Positive results from an important phase 3 clinical trial fueled optimism about the biotech.

Scientists working in lab

Oct 5, 2017 by Brian Feroldi

Why Regeneron Pharmaceuticals Dropped 11.3% in September

The release of phase 3 trial results that failed to impress led to a sinking share price.

Piggy bank on top of brown leaves and pumpkin

Oct 4, 2017 by Brian Feroldi, Chuck Saletta, Jason Hall, Timothy Green, and Cory Renauer

5 Top Stocks for October

Looking for a few great stocks to buy this month? Here are five top opportunities for you to consider.

Oct 4, 2017 by Brian Feroldi, Sean Williams, and George Budwell

3 High-Yield Billionaire Stocks

Searching for income? You can follow in the masters' footsteps by checking out these high-yield stocks.

Man handing over bills

Oct 3, 2017 by Brian Feroldi, Sean Williams, and George Budwell

3 High-Yield International Stocks

Looking for a big dividend payment in today's pricey market? Here are three stocks that show why you should look beyond the U.S. border.

AFREZZA1 copy 2

Oct 2, 2017 by Brian Feroldi

Why MannKind Corporation Popped Today

Traders cheer after management provided investors with a series of positive updates.

Scientist looking at microscope cancer research

Oct 2, 2017 by Brian Feroldi

Why Seres Therapeutics Inc. Stock Is Tanking Today

Results from a phase 1 study failed to impress investors.

Halozyme-IMG_3940-Final

Oct 3, 2017 by Brian Feroldi

1 Great Biotech Stock You Have Never Heard Of

Big pharma companies have thrown hundreds of millions of dollars at this small biotech. Should retail investors follow suit?

Business man no money in pocks

Sep 26, 2017 by Brian Feroldi

Here's Why TherapeuticsMD Inc Is Falling Today

Shares drop after the company released the pricing details of its just-announced secondary common stock offering.

Management team around conference table looking worried

Sep 21, 2017 by Brian Feroldi

Why Intercept Pharmaceuticals Is Tumbling Today

A safety announcement released today by the FDA raises renewed concerns about the company's only marketed drug.

Businessman with coins falling through his hands

Sep 20, 2017 by Brian Feroldi

Why Nabriva Therapeutics Shares Are Falling Today

The roller-coaster ride continues for this clinical-stage biotech's stock.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services